$FSLR

First Solar (FSLR) Has a Huge Backlog. Will New Orders Deliver the Cash?

First Solar (FSLR) has a $13.6B backlog with deliveries through 2030, but faces uncertainty over new order prices and policy impacts. Q2 2026 sales were $1.06B, down 4%, while net income rose 24% to $423M. Analysts have mixed views on pricing power and future cash flow, with targets ranging from $251 to $326. The company's valuation is debated amid tariff protections and manufacturing investments.

Original reporting
Published Oct 19, 2026, 3:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 3:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
First Solar (FSLR) Has a Huge Backlog. Will New Orders Deliver the Cash? — source image
Decision brief

The 30-second read

$FSLRBearishLow
01

Why it matters

The article highlights cash conversion risk, which may prompt short positions or caution for new long entries.

02

Market read

Provides a nuanced view of First Solar's financial health, useful for traders assessing short-term price risk.

03

What to watch

Potential upside from perovskite pilot line and upcoming South Carolina capacity expansion.

Relevance 4/10Novelty 2/10Timing: none

Background

First Solar reported Q2 2026 earnings with strong margins but negative operating cash flow; analysts have adjusted price targets amid policy uncertainty.

Company-level read

Ticker impact

$FSLRBearishMedium confidence
Context

Article examines First Solar's backlog, cash conversion, recent analyst price targets and Q2 earnings quality.

Expected impact

likely pressure as investors question cash generation and future pricing.

Evidence & confidence

Analyst downgrades and reduced price targets indicate market skepticism; operating cash flow was negative despite profit.

Market effects

Solar sector may see heightened scrutiny on cash conversion metrics as policy support wanes.

U.S. renewable equipment manufacturers could experience similar valuation pressure.

Limited; primarily affects investors focused on U.S. solar manufacturers.

Counterpoint

Backlog volume and domestic-content requirements could eventually translate into higher margins if tariffs hold.

Key entities

  • First Solar, Inc.

    U.S. solar module manufacturer with a large contracted backlog.

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$FSLRHigh

Why First Solar (FSLR) Stock Is Up Today

First Solar (FSLR) stock rose 1.8% after Truist Securities upgraded it to Buy with a $229 price target, citing improved pricing and demand forecasts. Shares later cooled to $180.10, up 1.3%. The upgrade follows a 32% YTD decline, with the analyst noting strong domestic demand and anti-stockpiling restrictions benefiting the company.

$FSLRHigh

Truist upgrades First Solar stock rating on stronger pricing outlook

Truist upgraded First Solar (FSLR) to Buy, raising its price target to $270 from $229. The upgrade is based on stronger pricing outlook and valuation reset, with a 17% increase in 2029 U.S. module ASP estimates. Truist forecasts strong U.S. solar installations and cites regulatory support. Other analysts have also upgraded FSLR, citing undervaluation and potential earnings drivers.

$FSLRHigh

Why is First Solar stock up over 2% today?

First Solar (FSLR) stock rose 2.4% in pre-market trading after Truist Securities upgraded it to 'Buy' and raised its price target to $270, citing favorable pricing and regulatory conditions. The stock is still below its 52-week high of $320.95. Analysts have largely positive ratings, with 26 Buys, 9 Holds, and 1 Sell. The broader market is mixed ahead of bank earnings season.